The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

[21] Midura RJ(2006)SRC inhibitors in metastatic bone disease Clin Cancer Res 12 6291s-799

[22] Muschler GF(2004)Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription Embo J 23 790-1340

[23] Schecroun N(1999)Chronic myeloid leukemia N Engl J Med 340 1330-4505

[24] Delloye C(2005)In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants Cancer Res 65 4500-6932

[25] Sammons J(2005)Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells Clin Cancer Res 11 6924-9189

[26] Ahmed N(2005)Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells Cancer Res 65 9185-972

[27] El-Sheemy M(2006)Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model Am J Pathol 168 962-207

[28] Hassan HT(2010)Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts Oncogene 29 3196-81

[29] Chan GK(2006)Bone-related gene profiles in developing calvaria Gene 372 71-910

[30] Miao D(1998)Advances in the osteoblast lineage Biochem Cell Biol 76 899-6949

[21] Midura RJ(2006)SRC inhibitors in metastatic bone disease Clin Cancer Res 12 6291s-799

[22] Muschler GF(2004)Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription Embo J 23 790-1340

[23] Schecroun N(1999)Chronic myeloid leukemia N Engl J Med 340 1330-4505

[24] Delloye C(2005)In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants Cancer Res 65 4500-6932

[25] Sammons J(2005)Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells Clin Cancer Res 11 6924-9189

[26] Ahmed N(2005)Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells Cancer Res 65 9185-972

[27] El-Sheemy M(2006)Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model Am J Pathol 168 962-207

[28] Hassan HT(2010)Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts Oncogene 29 3196-81

[29] Chan GK(2006)Bone-related gene profiles in developing calvaria Gene 372 71-910

[30] Miao D(1998)Advances in the osteoblast lineage Biochem Cell Biol 76 899-6949